Runhu Co., Ltd.: Sodium Diclofenac Sustained Release Tablets are expected to be selected for the 12th National Drug Procurement.

Runduo Co., Ltd. announced that the company is participating in the bidding for the 12th nationwide centralized drug procurement. According to the selection result notice released by the Joint Procurement Office on July 31, 2026, the company's product, diclofenac sodium sustained-release tablets, is expected to be selected for this centralized procurement. The procurement period will be from the effective date of the selection results until December 31, 2029.